Background: Inflammatory breast cancer (IBC) is rare and biologically aggressive. We sought to assess diagnostic and management strategies among the American Society of Breast Surgeons (ASBrS) membership.
Patients And Methods: An anonymous survey was distributed to ASBrS members from March to May 2023.